Concord Medical - Spon ADRCCM
13F holders, Q2 2025 (June 30)5holders +2
2new positions
0sold out
$5.73avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings, up 2 from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were UBS Group AG ($389K), Raymond James Financial Inc. ($5K) and Rhumbline Advisers ($1K).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 68,721 shares bought and 37 shares sold, net +68,684 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +31199.1% | 67,919 | $389K |
| Raymond James Financial Inc. | 0.00% | New | 919 | $5K |
| Rhumbline Advisers | 0.00% | Reduce -12.5% | 258 | $1K |
| Morgan Stanley | 0.00% | New | 100 | $573 |
| SBI Securities Co., Ltd. | 0.00% | No change | 4 | $23 |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.